In this point-prevalence survey followed by prospective audit and feedback at 4 tertiary-care hospitals in Calgary, Alberta, Canada, we evaluated whether intravenous amoxicillin-clavulanate may be used as a narrower-spectrum alternative to intravenous piperacillin-tazobactam for patients admitted to general surgery services.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028943 | PMC |
http://dx.doi.org/10.1017/ash.2023.133 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!